[{"address1": "Clarence Thomas Building", "address2": "P.O. Box 4649 Road Town", "city": "Tortola", "zip": "VG1110", "country": "British Virgin Islands", "phone": "203 221 7378", "website": "https://www.portagebiotech.com", "industry": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "Portage Biotech Inc., a clinical stage immune-oncology company, engages in the research and develops pharmaceutical and biotechnology products. Its product pipeline comprises PORT-8, a dual inhibitor of adenosine receptors 2A and 2B, which is in preclinical trial to treat solid tumors; PORT-9, an A2B antagonist, which is in pre-clinical stage program to treat colorectal and gastrointestinal cancers; and PORT-3, a polylactide-co-glycolide, which is in phase 1 to treat NY-ESO-1 positive tumors. The company also develops PORT-4, a nanolipogel co-formulations to treat of solid tumors that is in preclinical trials; and PORT-5, a VLP-STING to treat of solid tumors and is in preclinical trials. Portage Biotech Inc. is based in Tortola, British Virgin Islands.", "fullTimeEmployees": 7, "companyOfficers": [{"maxAge": 1, "name": "Dr. Ian B. Walters M.B.A., M.D.", "age": 55, "title": "CEO & Chairman of Board", "yearBorn": 1968, "fiscalYear": 2024, "totalPay": 717885, "exercisedValue": 0, "unexercisedValue": 695213}, {"maxAge": 1, "name": "Mr. Allan J. Lee Shaw CPA", "age": 59, "title": "Chief Financial Officer", "yearBorn": 1964, "fiscalYear": 2024, "totalPay": 518205, "exercisedValue": 0, "unexercisedValue": 311452}, {"maxAge": 1, "name": "Dr. Robert A. Kramer Ph.D.", "title": "Chief Scientific Officer", "fiscalYear": 2024, "totalPay": 185891, "exercisedValue": 0, "unexercisedValue": 128769}, {"maxAge": 1, "name": "Mr. Brian  Wiley", "age": 55, "title": "Chief Business Officer", "yearBorn": 1968, "fiscalYear": 2024, "totalPay": 155422, "exercisedValue": 0, "unexercisedValue": 130948}, {"maxAge": 1, "name": "Mr. Justin  Fairchild", "title": "Vice President of Development", "fiscalYear": 2024, "totalPay": 325301, "exercisedValue": 0, "unexercisedValue": 67798}, {"maxAge": 1, "name": "Mr. Joseph  Ciavarella", "title": "Chief Accounting Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "maxAge": 86400, "priceHint": 2, "previousClose": 6.39, "open": 6.39, "dayLow": 5.87, "dayHigh": 6.65, "regularMarketPreviousClose": 6.39, "regularMarketOpen": 6.39, "regularMarketDayLow": 5.87, "regularMarketDayHigh": 6.65, "beta": 100.476, "trailingPE": 0.272541, "forwardPE": -12.788463, "volume": 176950, "regularMarketVolume": 176950, "averageVolume": 935980, "averageVolume10days": 5533917, "averageDailyVolume10Day": 5533917, "bid": 6.41, "ask": 6.55, "bidSize": 100, "askSize": 100, "marketCap": 6974254, "fiftyTwoWeekLow": 2.1, "fiftyTwoWeekHigh": 61.98, "fiftyDayAverage": 3.7834, "twoHundredDayAverage": 11.97645, "currency": "USD", "enterpriseValue": 1026643, "floatShares": 594229, "sharesOutstanding": 1048760, "sharesShort": 7187, "sharesShortPriorMonth": 12098, "sharesShortPreviousMonthDate": 1721001600, "dateShortInterest": 1723680000, "sharesPercentSharesOut": 0.0069, "heldPercentInsiders": 0.36403, "heldPercentInstitutions": 0.09351, "shortRatio": 0.05, "shortPercentOfFloat": 0.010199999, "bookValue": 4.066, "priceToBook": 1.635514, "lastFiscalYearEnd": 1711843200, "nextFiscalYearEnd": 1743379200, "mostRecentQuarter": 1711843200, "netIncomeToCommon": -75339000, "trailingEps": 24.4, "forwardEps": -0.52, "enterpriseToEbitda": -0.056, "exchange": "NCM", "quoteType": "EQUITY", "symbol": "PRTG", "underlyingSymbol": "PRTG", "shortName": "Portage Biotech Inc.", "longName": "Portage Biotech Inc.", "firstTradeDateEpochUtc": 1009981800, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "c85b618a-5b14-3e35-9d8d-d4e5ddb2236b", "gmtOffSetMilliseconds": -14400000, "currentPrice": 6.65, "recommendationMean": 3.0, "recommendationKey": "hold", "totalCash": 5028000, "totalCashPerShare": 4.795, "ebitda": -18199000, "totalDebt": 47000, "quickRatio": 1.76, "currentRatio": 2.673, "debtToEquity": 1.412, "returnOnAssets": -0.21341999, "returnOnEquity": -1.9151, "freeCashflow": -8497925, "operatingCashflow": -14297000, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2024-08-29"}]